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Abstract  
 
Iron regulates mRNA translation initiation through RNA iron responsive element (IRE) 
 
By Jia Ma 
Advisor: Professor Dixie J. Goss 
The non-coding IRE-RNA structure, a 30 nt stem loop structure, regulates synthesis of proteins 
in iron trafficking, cell cycling, and nervous system function. IRE-RNA binding with iron 
regulatory protein (IRP) proteins inhibits ribosome accessing mRNA. Increasing iron 
concentration decreases IRP binding with IRE-RNA. Previous models of IRE-mRNA translation 
regulation concentrate on Fe-S binding to IRP and IRP degradation after release from IRE-RNA. 
These models lack information on the details of decreasing IRE-RNA/IRP protein binding with 
iron concentration elevation. This research shows 1. Eukaryotic initiation factor 4F (eIF4F) binds 
to IRE-RNA with high affinity and works as a positive control element in mRNA translation. 2. 
eIF4F, IRP competitively bind to IRE-RNA. 3. Fe
2+
 increases eIF4F/IRE-RNA binding affinity, 
which outcompetes IRP binding. 4. Fe
2+
 induces an IRE-RNA conformation change leading to 
changes in binding affinity with eIF4F and IRP. 5. M
7GTP cap doesn’t affect eIF4F or IPR1 
binding with 73 nt of the 5’ noncoding region mRNA which includes the IRE 6. eIF4F/IRE-RNA 
has a much longer life time than IRP1/IRE-RNA which suggests both kinetics and stability of the 
complexes are important. 7. eIF4G, a subunit of eIF4F, binds to IRE-RNA without other subunits.  
A novel regulatory mechanism is proposed where metabolic iron (Fe
2+
) induces IRE-RNA 
conformation change to decrease inhibitor protein (IRP) binding and increase activator protein 
(eIF4F) binding, indicating IRE-RNA act as a riboregulator.  
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Introduction 
Iron adsorption 
Iron, an essential nutrient for human beings, plays an important role in biochemical activities. 
Iron deficiency is the most prevalent nutrition disorder in the world (Zimmermann and Hurrell 
2007). However iron overload can damage body tissue (Shander, Berth et al. 2012) and may be 
related to increasing risk of human cancer (Stevens, Graubard et al. 1994; Kabat and Rohan 
2007). For adults,  male body iron  is about 3.8 gram and female body iron  is about 2.3 gram 
(Swanson 2003). In order to replenish iron loss from sweat, urine, sloughed intestinal mucosal 
cells, and other blood loss, people need to adsorb 1-2 mg of iron daily from food (Anderson, 
Shen et al. 2012; Shander, Berth et al. 2012). Humans adsorb iron through enterocyte in small 
intestines by divalent metal transport 1 (DMT1). Only the divalent iron form, ferrous (Fe
2+
) is 
suitable for adsorption. However 90% of dietary iron is in the ferric form (Fe
3+
) and the other 10% 
is in the heme form(Munoz, Garcia-Erce et al. 2011). In the intestinal lumen, ferric (Fe
3+
) is 
reduced to ferrous (Fe
2+
) by ferric reductases (Kohgo, Ikuta et al. 2008). DMT1 transports the 
diavalent ionic iron (Fe
2+
) across the enterocyte apical membrane (Franken, Lokman et al. 2011; 
Wang and Pantopoulos 2011).  The heme iron is transported to the enterocyte by unidentified 
heme transporters (Munoz, Garcia-Erce et al. 2011; Wang and Pantopoulos 2011).  In the 
enterocyte, transported heme will be metabolized into ferrous (Fig 1).  
After iron is adsorbed into the enterocyte, ferrous iron is exported across the basolateral 
membrane into the plasma by ferroportin.  Ferroportin iron export is coupled with oxidizing 
ferrous iron back into ferric iron by the transmembrane copper-dependent ferroxidase, hephaestin.  
The re-oxidized ferric iron is circulated in the plasma by binding with transferrin (Tf) (Swanson 
2003; Wang and Pantopoulos 2011). Transferrin not only maintains iron in a soluble form but 
also as the main iron vehicle delivers iron to different cells.  In humans, plasma transferrin iron 
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saturation indicates iron level: transferrin iron saturation around 30% shows normal iron level: 
transferrin iron saturation below 16% shows iron deficiency and  transferrin iron saturation 
above 45% shows iron overload. If plasma transferrin iron saturation goes over 60%, the 
accumulated free non-protein binding iron can damage organs (Hentze, Muckenthaler et al. 2010; 
Meyron-Holtz, Moshe-Belizowski et al. 2011; Munoz, Garcia-Erce et al. 2011).  Transferrin 
bound iron enters the target cells by transferrin receptor 1 (TfR1) mediated endocytosis. The 
transferrin receptor 1 (TfR1) has around 500-fold higher affinity for iron loaded transferrin 
(holo-Tf) than for iron released transferrin ( apo-Tf) (Wang and Pantopoulos 2011). The TfR1 
and Tf affinity changes help apo-Tf dissociation with TfR1 and enable recapture of Fe
3+
. In the 
target cell, released Fe
3+
 is reduced to Fe
2+ 
by metalloreductase Steap3 (Fig 2) (Ohgami, 
Campagna et al. 2005; Richardson, Lane et al. 2010).  
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Figure 1 Iron adsorption from intestinal lumen to enterocytes (Wang and Pantopoulos 2011)  
Enterocytes absorb inorganic or heme iron from the diet by DMT1 and excrete iron through 
ferroportin protein. Iron is reoxidized into ferric form in body plasma and binds to Tf.  
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Ferritin Protein 
Most cellular ferrous iron is used in mitochondria for enzymatic functions. The excess 
intracellular iron is stored in the iron storage protein, ferritin. From microorganism to human, 
ferritin is the protein that stores cellular iron in a water soluble, non-toxic way (Crichton and 
Declercq 2010).  Ferritin is a 12 nm diameter spherical protein with an 8 nm diameter  hollow 
center (Watt 2011).  Mammalian ferritin is a hetero-polymeric protein assembled by 24 subunits 
(Fig 3). Those 24 subunits are classified into two subunit types, the H and L subunits (Andrews 
2010; Watt 2011). Both types of subunits have similar 5 α helices structure but different amino 
acids sequence (Crichton and Declercq 2010). The H subunit has ferroxidase activity, oxidizing 
ferrous iron into ferric iron.  The L subunit lacks oxidizing activity but it provides the ligand for 
ferric binding and initiates iron nucleation (Friedman, Arosio et al. 2011).  In mammals, ferritin 
can be assembled in different proportions of H and L subunits, which are tissue specific. High 
proportion of H subunit ferritin is found in heart, kidney and bone marrow and high proportion 
of L subunits ferritin is found in liver and spleen (Friedman, Arosio et al. 2011; Meyron-Holtz, 
Moshe-Belizowski et al. 2011) .   
Besides iron utilization and storage, 3% to 5% total cellular iron forms an accessible and 
transient iron ion pool, which is named as liable iron pool (LIP) (Kruszewski 2003; Kruszewski 
and Iwanenko 2003; Wang and Pantopoulos 2011). The LIP consists of both ferrous (Fe
2+
) and 
ferric (Fe
3+
) ion associated with lower molecular weight chelators, such as citrate, phosphate and 
other organic ions (Gebauer and Hentze 2004). The cytosolic LIP hemostasis is directly related 
to the ferritin expression.  
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Figure 2  Cellular iron uptake (Wang and Pantopoulos 2011) 
Cell adsorbs iron through endocytosis by binding with transferrin receptors. Cellular iron is 
utilized in mitochondria for enzymatic activities and stored in ferritin to keep iron harmless. 
Liable iron pool indicates cellular iron level. 
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Figure 3  Ferritin molecular symmetry (Watt 2011) 
(a) Diagram illustrating the 24 subunits symmetry in ferritin (b) ferritin molecule viewed from 4-
fold symmetry axis. (c) ferritin molecule viewed from the 3-fold symmetry axis .  
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Ferritin has a dual role in LIP hemostasis. As the main iron storage protein, ferritin binds to iron 
to keep iron in a soluble state and away from harmful redox reaction. One ferritin can store up to 
4500 iron atoms in its hollow center (Andrews 2010), but ferritin can also release iron into LIP to 
stabilize the cellular iron level under low iron conditions (Preiss, Baron-Benhamou et al. 2003).   
Eukaryotic mRNA structure 
Gene expression starts with transcription of DNA into RNA, and followed by translation of RNA 
into protein.  As a messenger in gene expression, RNA provides a target in protein synthesis 
control. Most eukaryotic mRNA can be divided into 5 parts: capped 5’ end, 5’ noncoding region, 
open reading frame (ORF), 3’ noncoding region, and 3’ end poly A tails (Fig 4). Eukaryotic 
mRNA has m
7
GTP at the 5’end, which is a strong positive control element for mRNA translation 
and is required for most mRNA translation. The open reading frame encodes the amino acid 
sequence. Between the 5’end m7GTP cap and ORF is the 5’ noncoding region around hundred 
nucleotides. Several mRNA control elements can be found in the 5’ noncoding region, such as 
internal ribosome entry site (IRES), upstream open reading frame (uORFs), and small structure 
elements. Those elements have different effects on mRNA translation.  IRES can recruit the 
ribosome to mRNA independent of the m
7
GTP Cap. It has been shown there are at least 10% of 
cellular mRNA that initiates mRNA translation via IRES (Gebauer and Hentze 2004; Komar and 
Hatzoglou 2011). uORFs are small open reading frame which can reduce translation from the 
main ORF. The small structure elements in 5’noncoding region binding with protein and RNA 
usually have negative effects on mRNA translation. Poly A tail is the 25 to 200 adenine 
nucleotides added to the 3’end of mRNA and is a positive control element for mRNA translation. 
8 
 
Between the ORF and poly A tail is  3’ end noncoding region, which has 200 to 800 nucleotides 
responsible for stabilization and subcellular localization of the mRNA .  
 
 
 
 
 
 
 
 
 
Figure 4 Eukaryotic mRNA structure (Gebauer and Hentze 2004) 
The m
7
Gppp structure is at the 5’ends of mRNA and poly A structure is at the 3’end of mRNA. 
The green rectangle box shows 5’ noncoding region. The red rectangle box shows 3’ noncoding 
region. Green oval in the 5’ noncoding region indicates other protein and RNA binding sites in 
mRNA. 
 
 
 
9 
 
IRE/IRP system 
As an important protein for cellular iron hemostasis, ferritin protein expression is controlled at 
the translational level with the changes of iron concentration.  At the end of 20th century, 
researchers identified a hairpin structure located in the 5’ noncoding region of ferritin 
mRNA ,which is responsible for iron regulation of ferritin mRNA translation (Dix, Lin et al. 
1992),  and named it as iron responsive elements (IRE). The ferritin IRE has 30 nucleotides 
containing a 10 base pair stem with bulges and CAGUG terminal nucleotides. The unpaired C8 
bulge interrupts the stem and divides the helix into upper stem and lower stem. In the CAGUG 
terminal nucleotides, C: G pair up and form the –AGU- loop (Walden, Selezneva et al. 2006) 
(Fig 5). Soon after identifying the IRE, researchers found a protein binding to the IRE structure, 
the iron regulatory protein (IRP) (Muckenthaler, Gray et al. 1998).  IRP binding to the IRE in 
ferritin mRNA inhibits ferritin protein synthesis. IRP/IRE binding affinity changes with cellular 
iron level fluctuations, which leads to ferritin protein synthesis responding to iron levels.   IRP 
binds to ferritin IRE with high affinity at lower iron level and ferritin protein synthesis is 
inhibited which answers cellular needs of less iron storage protein. Whereas IRP binds to ferritin 
IRE with low affinity at high iron level and ferritin protein synthesis starts which is required by 
iron concentration elevation. The coordination between IRP/IRE binding affinity change and 
ferritin protein synthesis stabilizes cellular iron.    
By using nuclease protection analysis, researchers (Beard, Burton et al. 1996) found IRP binding 
spans the entire 30 nucleotide ferritin IRE structure. The ferritin IRE-RNA terminal loop and 
lower stem directly contact with the IRP protein. The A15, G16, U17 and C8 are the key 
nucleotides for IRP binding to ferritin IRE (Goss and Theil 2011).  NMR revealed that the bound 
ferritin IRE has significant conformational changes compared to free ferritin IRE. In free ferritin 
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IRE, A15 stacks on top of C14:G18 pair whereas in the protein-RNA complex A15 and U16 
stack together and stick out from the rest of the IRE structure.  Unlike the distorted C8 in 
unbound ferritin IRE, C8 is also extends away from the stem (Fig 5).   
Soon after identifying IRE in ferritin mRNA, IRE structures were also found in other mRNA 
encoding proteins for cellular iron metabolism such as ferroportin, succinate dehydrogenease, 
and mitochondrial aconitase(Anderson, Shen et al. 2012). Bedsides the 5’ noncoding regions, 
IREs are also found in some mRNA’s 3’noncoding region such as transferrin receptor protein 1 
and divalent metal transporter 1(Erlitzki, Long et al. 2002). In contrast to 5’ noncoding region 
IRE mRNA inhibition of translation by IRP binding to IRE, IRP binding to the 3’ noncoding 
region IRE has positive effects on mRNA translation.  By binding with 3’ noncoding IRE, IRP 
can inhibit mRNA degradation from the exosome, which increases the life time of the mRNA 
and protein synthesis (Erlitzki, Long et al. 2002). Two opposite effects on mRNA translation 
caused by IRP binding with IRE have same results in cellular iron regulation. The 3’ noncoding 
region IREs are found in iron acquisition proteins, and the 5’ noncoding region IREs are found in 
iron storage or utilization proteins.  At low iron concentration, cells need to transport 
extracellular iron into the cell which requires more iron acquisition proteins (Active translation 
by IRP/IRE binding). At the same time, there is no need to synthesize iron storage or utilization 
proteins which have 5’ noncoding region IREs (Repress translation by IRP/IRE binding).  At 
high iron concentration, the requirement is reversed. What cells need now is iron storage or 
utilization proteins (translation activation) not iron acquisition proteins (translation repression) 
(Fig 6) (Anderson, Shen et al. 2012).  By coordination of IREs, cellular iron concentration is 
stable at a constant level. 
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Genetically IRE is not a conservative element; IREs have 36% to 85% sequence difference even 
in a single organism. However all IREs have conserved structures: 9 to 10 base pair double stand 
RNA helix, terminal –CAGUGU/C- nucleotides and an unpaired C8 residue in the helix (Fig 7) 
(Piccinelli and Samuelsson 2007).  
Recently IRE structures are also been found in the amyloid precursor protein mRNA (Beard, 
Burton et al. 1996) and alpha synuclein mRNA (Proudhon, Wei et al. 1996), which implies iron 
plays a role in neurodegenerative diseases.  
Despite highly diversified IRE sequence, IRP can bind to all IREs. There are two types of IRP in 
the cell. IRP1 belongs to the cellular aconitase family which catalyzes the isomeriztion of  β-
hydroxy-acid metabolites. Active aconitases require an Fe-S cluster as a coenzyme. IRP1 is the 
apoenzyme of cellular aconitase which only binds to IRE without the Fe-S cluster.  IRP1 is 
composed of 4 domains. Domain 1 and domain 2 are stable and form the core of IRP1 which is 
responsible for aconitase activity. Conformation changes occur in domain 3 and domain 4 when 
IRP binds to IRE.  The domain 3 rotates 52º and translates ~13 Å and domain 4 rotates 32º and 
translates ~14 Å (Fig 5) (Walden, Selezneva et al. 2006). IRP2 has 60% sequence identity to 
IRP1, which doesn’t bind Fe-S and does not have any enzyme activity.  The unbound IRP2 is 
readily degraded.  
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Figure 5 Structure of rabbit IRP1 in complex with ferritin H IRE-RNA. 
(A) Stereo diagram of IRP1:IRE-RNA complex showing IRP binding with IRE (Ma, Haldar et al. 
2012). (B)The IRE-RNA diagram showing the upper stem, lower stem, terminal loop and bulge 
C8. C8 and A15 labeling in red. (C) Free IRP conformation (Left) and conformation in complex 
with IRE-RNA (Right), 4 domain labeled in different color (Walden, Selezneva et al. 2006)and 
(D) Twisted IRE-RNA structure after binding with IRP (Walden, Selezneva et al. 2006) 
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Figure 6 IRPs regulate translation and stability of IRE-containing mRNAs (Anderson, Shen et al. 
2012). 
IRPs bind to IREs located in either the 5’ or 3’ noncoding region of IRE-mRNAs. At low iron 
level, IRPs bind to both 5’ IRE and to 3’ IRE with high affinity. 5’ IRE-mRNA translation is 
repressed to inhibit iron storage and utilization protein synthesis such as ferritin. And 3’ IRE-
mRNA translation is activated to synthesize iron transporter protein such as TfR1.  At high iron 
level, IRPs do not bind any IREs.  5’ IRE-mRNA translates into protein such as ferritin to lower 
iron level. The 3’ IRE-mRNA is degraded to inhibit iron uptake.   
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Figure 7  IREs in different mRNAs (Piccinelli and Samuelsson 2007)  
The Listed IREs include Transferrin receptors (Tfr), mitochondrial aconitase (mACO), erythroid 
aminolevulinic synthase (eALAS), ferroportin, divalent metal ion transporter (DMT1) , succinate 
dehydrogenase (SD), myotonic dystrophy kinase-related Cdc42-binding kinase α (MRCKα), and 
cell division cycle 14a (Cdc14a). 
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Eukaryotic Translation Initiation   
The 5’ noncoding region IRE is a well-known negative control element in mRNA translation. 
However, how mRNA translation gets inhibited is still not clear. Cellular mRNA translation has 
3 steps: initiation, elongation and termination. Translation initiation is the most complicated and 
tightest controlled process compared to elongation and termination (Dever 1999; Kozak 2002; 
Schutz, Bumann et al. 2008). The eukaryotic initiation starts with 43S pre-initiation complex 
binding to mRNA and finishes with positioning 80S ribosome at the AUG codon.  There are at 
least 12 eukaryotic initiation factors (eIF) (Gebauer and Hentze 2004) involved in this process. 
Eukaryotic initiation can be divided into 3 main steps: mRNA preparation, 43S complex binding 
to mRNA, and 80S ribosome formation.   
Eukaryotic protein synthesis occurs on a circular mRNA, which needs eIF assistance. The 
eukaryotic initiation factor 4F (eIF4F) binds to the 5’cap of mRNA and poly A binding protein 
(PABP) binds to the 3’ poly A tail of mRNA. PABP also binds to eIF4F, which enables both 
5’end and 3’end of mRNA to bind to eIF4F and circularize mRNA.  eIF4F is a protein complex, 
which is composed of three eIFs in mammalian cells:  eIF4A, an ATP dependent RNA helicase , 
unwinds secondary structure in 5’ noncoding region; eIF4E, the cap binding  protein, binds to 5’ 
cap of mRNA ; and eIF4G, a scaffold protein, has binding domains for other factors such as 
PABP. In translation initiation, the 40S subunit of the ribosome binds Met-tRNAi
Met
, eIF2, 
eIF2B, eIF3, eIF1 and eIF1A to form 43S complex. By eIF3 binding to eIF4G, the 43S complex 
can access the mRNA. When a 43S complex binds to mRNA, it starts to scan to the first AUG 
codon (Preiss and M 2003). After 43S complex reaches the first AUG codon, the initiation 
factors are released from the 43S complex and 60S ribosome subunit joins to assemble 80S 
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ribosome. The formation of the 80S ribosome indicates finish of translation initiation and start of 
translation elongation (Fig 8) (Gebauer and Hentze 2004).  
mRNA translation regulation happens on two levels: global control and mRNA specific control. 
Global control affects all mRNA translation which usually happens with the initiation factor 
modification such as HSV-1 repressing cellular mRNA translation by phosphorylation of eIF4E 
(Walsh and Mohr 2004).  In specific control, mRNA expression is regulated by RNA specific 
hybridizing to noncoding region of mRNA or some protein binding to noncoding region of 
mRNA such as IRP binding to IRE. (Gebauer and Hentze 2004) 
Research shows that IRP1 binding to IRE prevent 43S complex accessing the mRNA (Paraskeva, 
Gray et al. 1999; Gebauer and Hentze 2004), which implies that IRP/IRE interacts with the RNA 
preparation step to inhibit translation initiation. Among all eukaryotic initiation factors, eIF4F 
firstly binds to 5’ cap of mRNA. Researchers also proved that IRP/IRE interacts with eIF4F to 
prevent ribosome accessing the mRNA (Muckenthaler, Gray et al. 1998). However how does 
IRP/IRE interact with eIF4F was not clear.  
In this thesis, the relationship among eIF4F, IRP and IRE is clarified. By using the fluorescence 
techniques, the eIF4F was proved to bind with IRE, and the binding affinity of eIF4F and IRE 
was quantitatively measured. The experiments proved that eIF4F competitively binds to IRE 
with IRP, which indicates that IRP/IRE blocks mRNA translation by inhibiting eIF4F accessing 
IRE. In order to understand the regulation of cellular iron metabolism, the iron’s effects on 
eIF4F/IRE binding and IRE conformation were also tested. The results showed that iron 
concentration changes have opposite effects on eIF4F/IRE binding, compared with IRP/IRE 
binding, and iron induces IRE’ conformation change. Combing all results, a novel mechanism of 
mRNA translation regulated through IRP/IRE was revealed.  
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Figure 8 Cap-dependent translation intiation.  (Gebauer and Hentze 2004) 
Translation initiation with 3 steps; mRNA preparation, 43S complex binding to mRNA, 80S 
ribosome formation.  All initiation factors are listed in the cartoon.  
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Method 
Fluorescence Techniques 
In order to study the relationship between eIF4F with IRP/IRE, techniques to measure 
biomolecular interactions were used in this study. Bimolecular interaction analysis includes 
filter-binding assay, electrophoretic mobility shift assay (EMSA), isothermal titration 
calorimetry (ITC) and fluorescence measurement. In this research, powerful fluorescence 
techniques are chosen to study the biomolecular interactions. The fluorescence can measure 
affinity in solution giving true equilibrium binding constants compared with other methods such 
as filter-binding assay and EMSA. The ITC also can be measured in solution, but it needs more 
material and higher concentration compared with fluorescence (Anderson, Larkin et al. 2008).  
In fluorescence measurements, emission intensity and anisotropy are two main methods to detect 
environmental changes and molecular motion. Emission intensity can be changed when 
fluorescence producing substance such as protein binds to the other substance such as RNA. By 
measuring the fluorescence intensity change, the binding affinity between two molecules can be 
quantified. Fluorescence anisotropy detects the rotation of a fluorophore by exciting the 
fluorophore with a polarized excitation light. If the excitation is vertical (Ivv), the anisotropy is 
measured by the vertical (Ivv) and horizontal (Ivh) emission beam (Fig 9). The anisotropy is 
calculated by the following equation  
 
If a fluorophore rotates slower in solution than the fluorescent life time, the anisotropy will be 
large because I‖ value is larger than I⊥ value. If a fluorophore rotates rapidly relatively to its life 
time; the anisotropy will be close to zero because I‖ value is equal to I⊥ value. The binding of 
r= (Ivv- Ivh)/ (Ivv+2Ivh) 
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protein to a fluorophore labeled RNA, the increase of mass is sufficient to decrease the rotation 
rate of the fluorophore and change the anisotropy (Anderson, Larkin et al. 2008).  
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Figure 9 Geometry of fluorescence anisotropy experiment (Visser. Antonie J and Rolinski. Olaf). 
The polarized light excites the fluorophores in the cuvette. The emission intensity of vertically 
(Ivv) and horizontally (Ivh) polarized fluorescence is measured  
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Protein preparation  
The proteins used in this research is listed in Table 1  
The eIF4F protein was kindly provided by Professor William C. Merrick and purified from 
rabbit reticulocyte lysate (RRL) as described  (Grifo, Tahara et al. 1983). 
The IRP1 was kindly provided by Professor Elisabeth C. Theil and purified from yeast as 
described in reference (Erlitzki, Long et al. 2002; Khan, Walden et al. 2009).  
All eIF4G proteins were expressed in BL21 cells and induced by 0.8 mM IPTG at 15 °C. The 
induced cells were collected by centrifugation at 4500 rpm. The harvested cells were suspended 
in PBS buffer and sonicated. The sonicated cell lysate was centrifuged at 13500 rpm for 30 mins. 
After centrifugation, the supernatant was filtered by 0.45 µM filter and loaded to GS Trap FF 
(GE healthcare life science). The column was washed by PBS buffer and eluted by elution buffer 
(50 mM Tris·HCl pH 8.0 and 20 mM reduced Glutathione). The eluted protein was transferred to 
10 kDa cutoff dialysis bag and dialyzed in two Liter dialysis buffer (50 mM potassium acetate 
KOAc, 20 mM Tris·HCl pH 8.0 0.1 mM EDTA, 1 mM DTT and 10% glycerol). After overnight 
dialysis, the protein was concentrated by dialysis against PEG 8000 for 20 min. The concentrated 
protein was stored at -80 °C for future use. The purity of the protein was tested by 12% SDS-
PAGE and the concentration of protein was determined by the Bradford method with bovine 
serum albumin as the standard using a Bio-Rad protein assay reagent. 
 
 
 
 
 
22 
 
 
 
 
 
Table 1Proteins used in iron regulating eukaryotic mRNA translation initiation. 
 
 
 
 
 
 
 
 
 
Protein  Vector Host Purification  
eIF4G M domain (626-1045) pGEX-4T-eIF4G(M) E.coli BL21 GS Trap FF (GE 
healthcare  life 
Science) 
eIF4G C terminal domain 
(1045-1560) 
pGEX-4T-eIF4G(C) E.coli BL21 GS Trap FF (GE 
healthcare  life 
Science) 
eIF4F (Mammalian) Kindly provided by Professor Merrick  
IRP1  Kindly provided by Professor Theil  
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RNA preparation  
The oligosnucleotides are listed in Table 2 
Fluorescein-labeled 30 nt ferritin IRE-RNA, Fluorescein-labeled 25 nt mitochondrial aconitase 
IRE-RNA, 2-aminopurine substituted 30 nt IRE-RNA, and 73 nt ferritin mRNA noncoding 
region DNA oligos (template for in vitro RNA transcription) were purchased from Genelink or 
IDT (Table 2). After dissolving  in  titration buffer (40 mM HEPES, pH 7.2, 100 mM KCl, 5% 
glycerol), all RNAs were melted at 85 °C for 15 min and reannealed by  slowly cooling to 25 °C 
before use.  The concentrations of RNA were determined spectrophotometrically from the 
measured absorbance at 260 nm with 1.0 A260/mL = 40 μg/mL RNA. 
RNA Transcription and Capping 
The 73nt ferritin mRNA noncoding region was transcribed by T7 RNA polymerase at 37 °C for 
4 hours. The transcription system was listed in the following Table 2. The purchased DNA oligos 
with T7 promoter sequence (italicized in the table 1) were dissolved in titration buffer. The 
positive strand DNA and negative strand DNA were mixed by 1:1 ratio, melted at 85 °C for 
5 min and annealed at room temperature to form the final transcription template. After 
transcription, the RNA was purified by RNA purification kit (Zymo Research) and the 
concentration was quantified by absorbance at 260 nm with 1.0 A260/mL = 40 μg/mL RNA. The 
RNA was capped by vaccinia capping enzyme system (listed in Table 4) at 25 °C for 3 hours. 
RNA capping efficiency is tested by Malachite Green Phosphate Assay. (Feng, Chen et al. 2011) 
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Name Sequence Sources 
Fluorescence labeled Ferritin IRE-
RNA 
FL5’GUUCUUGCUUCAACAGUGUUG
AACGGAAC3’  
Genelink 
Fluorescence labeled mitochondrial 
aconitase IRE  
FL5’UCAUCUUUGUCAGUGCACAAA
AUGG3’ 
Genelink 
Fluorescence labeled 5S RNA  FL5’UAGUACUUGGAUGGGAGACCG
CCUGGGAAU3’ 
IDT 
73 nt ferritin  5’ noncoding region 
DNA Positive strand 
5’TAATACGACTCACTATAGGGATCTA
CACCTGACTCTTAGTAGAGTTCTTG
CTTCAACAGTGTTTGAACGGAACCC
TCTCTGAGTCCTTTGCTC3’ 
IDT 
73 nt ferritin 5’ noncoding region 
DNA Reverse strand 
5’GAGCAAAGGACTCAGAGAGGGTT
CCGTTCAAACACTGTTGAAGCAAG
AACTCTACTAAGAGTCAGGTGTAG
ATCCCTATAGTGAGTCGTATTA3’ 
IDT 
2-aminopurine substituted C8 Ferritin 
IRE-RNA 
5’GUUCUUG-2AP-
UUCAACAGUGUUGAACGGAAC3’ 
IDT 
2-aminopurine substituted A15 
Ferritin IRE-RNA 
5’GUUCUUGCUUCAAC-2AP-
GUGUUGAACGGAAC3’ 
IDT 
      
 
Table 2 Purchased nucleotides 
 FL: Fluorescein labeled;  Italic bases:  T7 promoter 
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Ingredients  Concentration Ingredients  Concentration 
NTPs 5 mM for each Pyrophosphatase  0.1 unit/ mL  
GMP 5 mM RNase Out 0.2 unit/ mL  
Mg
2+
 20 mM T7 RNA polymerase 50 units/ mL 
PEG 8000 5% Tris·HCl (pH 8.0) 40 µM 
DTT 10 mM Triton X-100 0.01% 
Spermidine 1 mM DNA template  5 mM 
 
Table 3 Transcription System 
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Ingredients Concentration Ingredients Concentration 
GTP  2 mM Vaccinia capping 
enzyme  
1 units / mL 
S-Adenosyl 
methionine (SAMs) 
1 mM Tris·HCl (pH 8.0) 50 µM 
KCl 5 mM MgCl2 1 mM 
DTT 1 mM   
 
Table 4 RNA m
7
GTP Capping system 
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Eukaryotic initiation factors (eIFs) binding to IRE-RNA. 
The equilibrium constants for eIF4F, eIF4G(M) and eIF4G(C) binding to ferritin IRE-RNA were 
separately determined by monitoring the fluorescence anisotropy change.   Fluorescein labeled 
ferritin IRE-RNA (50 nM) was titrated by eIFs in buffer (20 mM HEPEs, pH 7.4, 100 mM KCl) 
at 25 °C. The KD values were determined by fitting the plot of changes in anisotropy vs. eIFs 
concentration using the equation robs = rmin + {(rmax-rmin)/(2[IRE])}{b-(b
2
 - 4[IRE][eIF4F])
0.5
}  
where the robs is the observed anisotropy value; rmin the minimal anisotropy value; rmax is final 
saturated anisotropy value; [IRE] and [eIF4F] are the total concentrations of IRE-RNA and 
eIF4F protein, respectively; b = KD + [IRE] + [eIF4F] as described (Luo and Goss 2001; Khan 
and Goss 2005). Data were fit to equations by using KaleidaGraph (Abelbeck Software). For the 
metal ions’ effects on eIF4F/IRE binding, various concentrations of metal ions, such as Fe2+ 
(titration is carried in an inert atmosphere )and Mn
2+
, were added to titration buffer before 
titration. Other procedures and calculation are similar to previous describe.  
eIF4G binding to 5’ noncoding region of ferritin mRNA (73nt). 
The equilibrium constants for eIF4F binding to 5’ noncoding region of ferritin mRNA (73nt) 
were determined by monitoring the intrinsic fluorescence intensity change of eIF4F.   eIF4F (50 
nM) was titrated by RNA in buffer (20 mM HEPEs, pH 7.4, 100 mM KCl) at 25 °C. The KD 
values were determined by fitting the plot of changes in fluorescence intensity vs. RNA 
concentration using the equation F= {2F0KD- F∞*b+ F∞*(b
2
-4 [eIF4F][RNA])
1/2 
}/{b+ (b
2
-4 
[eIF4F][RNA])
1/2 
}(Thorp, McKenzie et al. 1996) where F0 : fluorescence intensity before 
titration, F∞ : fluorescence intensity when IRE saturated binding with eIF4F, b= KD +[eIF4F] + 
[RNA]   as described. Data were fit to equations by using KaleidaGraph (Abelbeck Software). 
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eIF4F and IRP Competitive Binding for IRE-RNA. 
Fluorescein labeled ferritin IRE-RNA (50 nM) was mixed with varying concentrations of eIF4F 
protein.  The eIF4F and FL-ferritin IRE-RNA mixture was titrated by IRP1 protein as described 
above. The data were analyzed using the Lineweaver–Burke plot, 1/r-robs vs 1/[IRP]. Intersection 
of the lines at the same point on the Y-axis indicated competitive binding contrasting with the 
parallel lines that would be observed for uncompetitive binding. Data were fit by using 
KaleidaGraph (Abelbeck Software). 
IRE-RNA conformation changes with iron concentration changes 
Freshly prepared solutions of FeSO4 in deoxygenated (argon-purged) water were titrated 
anaerobically to argon-purged solutions of the reannealed 2AP substituted IRE-RNAs (50 nM), 
and the fluorescence change of 2AP was monitored at the same time. The experiments were 
performed in an inert atmosphere as described (Khan, Walden et al. 2009).  
Kinetics study of eIF4F/IRE-RNA binding 
By using OLIS RSM 1000 stopped-flow system (Fig 10), the binding of IRE-RNA and eIF4F 
protein was monitored by anisotropy change with 1-ms dead time at 25 °C after rapid mixing 
200 nM fluorescein labeled IRE-RNA with 200 nM  eIF4F protein. The fluorescein labeled 
Ferrtin IRE-RNA was excited at 490 nm and the emission is detected using a 500 nm cut-on 
filter. All measurements were performed in titration buffer, 40 mM HEPES, pH 7.2, 100 mM 
KCl, 5% glycerol and 2% 2-mercaptoethanol. 1000 pairs of data were collected in one mixing 
shot. In order to improve signal-to noise ratio, 5 sets of data were averaged.  The averaged set of 
data was fitted to heterogeneous 2nd order reaction by using Global analysis software provided 
by OLIS.    
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Figure 10  OLIS RSM 1000 stopped-flow system 
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Results 
eIF4F binds to Ferritin  IRE-RNA not control 5S RNA 
Previous research showed that as a negative control element IRP/IRE complexes stability 
responds to cellular iron concentration changes. Previous studies  (Dix, Lin et al. 1992) showed 
that in the IRP depletion system, ferritin mRNA translation efficiency is lower in the IRE 
deletion mutation than the m
7
GTP cap deletion mutation which has whole ferritin mRNA 
without m
7
GTP cap. Those data showed that IRE may be a positive element in translation. The 
eIF4F/IRE binding assay showed that eIF4F binds to IRE-RNA (KD =39.8±5.6 nM) but not 5S 
RNA (KD >1 mM) (Fig 11). eIF4F specifically binding to IRE-RNA indicates that IRE can help 
the ribosome locate on the mRNA,  which is consistent with IRE functioning as a positive 
control element in translation.   
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Figure 11 eIF4F binding to ferritin IRE -RNA 
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.) 
labeled RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, emission- 520 nm)  in 
titration buffer. eIF4F tightly binds to ferritin IRE-RNA  (KD =39.8±5.6 nM) but not 5S RNA 
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Metal ion’s effects on eIF4F/IRE-RNA complexes 
After increasing the iron concentration anaerobically to 50 µM in titration buffer, eIF4F/IRE 
RNA binding affinity increases (KD =9.5±2.4 nM) (Fig 12, 15), which is similar to binding 
affinity between eIF4F and encephalomyocarditis virus (EMCV) RNA and tighter than binding 
affinity between eIF4F and β-globing mRNA (Lomakin, Hellen et al. 2000).  Other metal ion’s 
effects on eIF4F/IRE binding were tested.  Mn
2+
, whose size is similar to Fe
2+
, had the same 
effect on eIF4F/IRE binding as Fe
2+
 (Fig 14, 15); whereas another divalent ion, Mg
2+
, also 
increased the eIF4F/IRE binding but the strength was not as much as Fe
2+
 or Mn
2+
 (Fig 13,15) 
(Table 5).  Data show that 1000 µM Mg
2+
 has similar effects on eIF4F/IRE binding as 5 µM Fe
2+
 
or Mn
2+
.  By conjoining the data (Ma, Haldar et al. 2012), the metal has opposite effects on 
IRP/IRE binding in contrast to eIF4F/IRE binding (Fig 17).  
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Figure 12 eIF4F/ IRE –RNA binding affinity increases with iron concentration elevation. 
50 µM FeSO4 added to anaerobic titration buffer with IRE-RNA (50 nM for 0 50 µM FeSO4 and 
20 nM for 50 µM FeSO4) before titration experiment.  Iron (50 µM FeSO4) increases IF4F/IRE 
binding affinity (KD=9.5±2.4 nM).  
 
34 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 eIF4F/ IRE –RNA binding affinity increases with 1mM MgCl2. 
eIF4F/ IRE-RNA binding affinity increases with 1mM MgCl2 (KD=29.9±6.9 nM). 
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Figure 14 Mn
2+
 and Fe
2+
 have similar effects on eIF4F/ IRE –RNA binding. 
eIF4F is titrated to 25 nM 5’ fluorescein(Ohgami, Campagna et al.) labeled IRE-RNA. 50 µM 
Mn
2+ 
(Circle ○) increases eIF4F/IRE-RNA binding affinity , which is similar to 50 µM Fe2+ 
(Diamond ◊) 
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Figure 15 Metal ion affects eIF4F-IRE binding 
Fe
2+
/Mn
2+
 have large effect on eIF4F-IRE binding compared to Mg
2+
.  (Black bar: No metal ion; 
Blue bar: Mg
2+
; Green bar: Mn
2+
; Red bar: Fe
2+
) The concentration of each metal ion is 
indicated on the X axis.  
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Table 5 Metal ion affects eIF4F-IRE binding 
*The concentration is not tested.  
 
 
 
 
 
 
 
 
 Mn
2+
 Fe
2+
 Mg
2+
 
0 µM 39.8±5.6 nM 
 
5 µM 25.1±3.5 nM 31.2±3.6 nM * 
25 µM 16.8±5.6  nM 17.7±4.9 nM * 
50 µM 9.4±2.9  nM 9.5±2.4 nM * 
1000 µM * * 29.9±6.9 nM 
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IRP, eIF4F competitively binds to ferritin IRE-RNA 
eIF4F binding to IRE raises a question: What is the relationship among eIF4F, IRP and IRE-
RNA.  
The competitive binding experiments were conducted. IRP was added to eIF4F/IRE complexes 
(various eIF4F concentrations). After using Lineweaver-Burk plot to analyze the competitive 
experiments, the results showed that eIF4F and IRP competitively bind to IRE-RNA (Fig 16).  
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Figure 16 Competitive binding of eIF4F and IRP1 to Ferritin IRE-RNA 
50 nM ferritin IRE-RNA with various concentration of eIF4F (Triangle, 0 nM; circle, 10 nM; 
square, 20 nM) was titrated with IRP1 protein. Convergence of lines (1/[IRP] vs 1/∆r ) on the Y 
axis (circle) indicates competitive binding 
 
 
 
 
40 
 
Iron induces ferritin IRE conformation change 
Since IRP and eIF4F competitively bind to ferritin IRE-RNA, iron has opposite effects on those 
two proteins’ binding with ferritin IRE-RNA (Fig 17). Iron decreases IRP/IRE binding affinity, 
but iron increases binding affinity of eIF4F/IRE, which answers the cellular requirement for 
more iron storage protein to stabilize the cellular iron level. However, previous IRP/IRE mRNA 
regulatory mechanism only focused on iron induced protein conformational change of IRP. Now 
results show that iron also has effects on eIF4F/IRE binding, which suggests another regulatory 
mechanism.  Iron might induce IRE-RNA’s conformational change. To test IRE-RNA 
conformational change with different iron concentrations, 2 aminopurine (2AP) was used to 
substitute key bases (C8 and A15) in ferritin IRE-RNA. 2 aminopurine, a fluorescent base analog 
of guanine and adenine, has been widely used in nucleic acid conformation research for its 
fluorescence intensity changes with environmental change (Barnes, Theil et al. 1998).  When 
2AP stacks with other bases, 2AP’s fluorescence is quenched and fluorescence intensity 
decreases. In my research, two key bases of IRE-RNA, C8 and A15, in IRP/IRE binding were 
replaced by 2 AP individually. As stated before, C8 is oriented away from the stem and A15 
stacks with G16 required in IRP/IRE binding state. Firstly, iron has only minor effects on 
fluorescence intensity of 2AP alone decreasing the intensity by less than 10% (Fig 18). It was 
found find that iron decreased fluorescence intensity by around 75% of 2AP substituted C8 
ferritin IRE-RNA substitute (Fig 19, 21). In contrast to C8,  the fluorescence intensity of A15 
substituted IRE-RNA increased by around 100% (Fig 20, 21).  C8 substitute IRE-RNA 
fluorescence decrease most likely is caused by C8 interacts with the stem of IRE upon addition 
of iron. A15 substitute IRE-RNA intensity increase suggests A15 is less stacked with G16 upon 
increased iron concentration.  Those two changes are predicted to have negative effects on 
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IRP/IRE binding. The key for IRE binding to IRP is the C8 oriented away from stem (Fig 5D). 
The C8 is inserted into a pocket in the IRP1 domain 4 and sandwiched between 2 arginine 
residues (Walden, Selezneva et al. 2006).  The A15 stacking G16 is also required for IRP/IRE 
binding (Fig 5D). The pair of A15 and G16 extends into a cavity of the IRP and interacts with 
residues inside of cavity (Walden, Selezneva et al. 2006). With the increased iron concentration, 
the IRE conformation changes lead to C8 interacting with stem and A15, G16 pair separating 
which explains IRP/IRE binding affinity decreasing.  
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Figure 17 Opposite effects of anaerobic Fe2+ on ferritin IRE-RNA binding of IRP and eIF4F. 
eIF4F-IRE with Fe
2+
 █ (from panel A); IRP1-IRE-RNA with Fe2+ █  Data of IRP1 binding to 
ferritin IRE-RNA is from  (Khan, Walden et al. 2009) 
 
 
 
 
 
 
43 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 Iron has minor effects on the fluorescence intensity of 2 amino purine 
The fluorescence spectra of 50 nM 2AP in anaerobic titration buffer with different FeSO4 
concentrations (Excitation: 330 nm).  
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Figure 19 Iron decreases the fluorescence intensity of 2AP substituted C8 ferritin IRE-RNA. 
The fluorescence spectra of 50 nM of 2AP substituted C8 ferritin IRE-RNA in anaerobic titration 
buffer with different FeSO4 concentrations (Excitation: 330 nm).  
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Figure 20 Iron increases the fluorescence intensity of 2 AP substituted A15 ferritin IRE-RNA. 
The fluorescence spectra of 50 nM 2 AP substituted A15 ferritin IRE-RNA in anaerobic titration 
buffer with different FeSO4 concentrations ( Excitation: 330 nm).  
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Figure 21 Iron’s effect on the IRE-RNA substituted with 2AP at A15 and the IRE-RNA 
substituted with 2AP at C8. 
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eIF4F also binds to mitochondrial aconitase IRE-RNA. 
In order to determine eIF4F binding to other IRE-RNA, binding affinity of eIF4F with 
mitochondrial aconitase IRE-RNA was also tested (Fig 22). The anisotropy experiment showed 
that eIF4F had similar binding affinity to ferritin IRE-RNA as compared to mitochondrial 
aconitase IRE-RNA (KD=32.9±5.4 nM) (Fig 23). 
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Figure 22 eIF4F binds to mitochondrial aconitase IRE –RNA 
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.) 
labeled mitochondrial aconitase IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, 
emission- 520 nm)  in titration buffer. eIF4F binds to  mitochondrial aconitase IRE-RNA with 
high affinity (KD=32.9±5.4 nM). 
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Figure 23 eIF4F has similar binding affinity to mitochondrial aconitase IRE-RNA and ferritin 
IRE-RNA.  
eIF4F was added to 50 nM 5’ fluorescein(Ohgami, Campagna et al.) labeled IRE-RNA. eIF4F 
binding to  mitochondrial aconitase IRE-RNA (Circle ) (KD=32.9±5.4 nM) was similar  to eIF4F 
binding to ferritin IRE-RNA (Diamond) (KD=39.8±5.6 nM). 
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eIF4F/IRE-RNA kinetic study  
In order to further understand the relationship among eIF4F, IRP1 and IRE-RNA, stopped-flow 
was used to study the kinetic reaction of eIF4F/IRE-RNA binding. The eIF4F/IRE-RNA binding 
was a heterogeneous second order reaction (Fig 24) and the forward reaction rate constant, 
kon ,was 2.07 ± 0.1 µM
-1
s
-1
 (Fig 24). 
Equation, 
 
 
  kon [IRE-RNAfinal+ Proteinfinal]+koff  (Wickiser, Cheah et al. 2005), was used to 
calculate the life time of eIF4F/IRE-RNA complexes (Table 6). The life time of eIF4F/IRE-RNA 
complex was 3.65 s. Using the data from lab member Dr. Mateen Khan, the life time of 
IRP/IRE-RNA complexes was 0.031 s which is much shorter than eIF4F/IRE-RNA complex 
(Table 5). The shorter lifetime of IRP/IRE-RNA indicates that IRP/IRE-RNA complex as a 
regulator system responds promptly to cellular conditional changes. As a positive control 
element eIF4F/IRE-RNA complex may stabilize circularized mRNA in the translational process, 
which has a longer lifetime.   
 
 
. 
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Figure 24 Kinetic study of eIF4F binding to ferritin IRE-RNA 
Fluorescence labeled Ferritin IRE-RNA (100 nM) was mixed with eIF4F (100 nM) by stopped 
flow. The anisotropy change was recoded with time (1 ms dead time). Data were fitted to 2
nd
 
order heterogeneous reaction: forward reaction rate = kon * [eIF4F] * [IRE].  kon =2.07 ± 0.1 µM
-
1
s
-1
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Table 6 Life time of eIF4F/ ferritin IRE-RNA complexes and IRP1/ ferritin IRE-RNA complexes 
*
IRE-RNA+ IRP1 data are from lab member Dr. Mateen Khan’s research.  
*
The result of koff  (IRE-RNA+4F ) was calculated by using the equation: koff = kon / KD 
 
 
 
 
 
 
 
 
 
  IRE-RNA + 4F IRE-RNA + IRP1 
*
 
kon (µM
-1
s
-1
) 2.07 ± 0.1 397 ± 7.3 
koff  (s
-1
) 0.08
*
 6.2 ± 0.3 
KD (nM) 39.8 ± 0.1 15.6 
τ (s) 3.65 0.031 
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m
7
GTP cap effects on eIF4F or IRP1 binding to 5’ noncoding region of ferritin mRNA. 
Compared to other mRNA translation control elements such as poly A tail, the m
7
GTP cap is the 
closest mRNA translation control element to ferritin IRE (within 50 nucleotides). In order to 
understand the relationship between m7GTP cap with IRE-RNA, the first 73 nt of ferritin mRNA 
(including IRE) were made by in vitro transcription (Fig 25). The study was carried to learn the 
difference between capped and non-capped the first 73 nt 5’ noncoding region of ferritin mRNA 
binding with eIF4F or IRP1.  
eIF4F binding to capped or non-capped 73 nt of ferritin mRNA was monitored by fluorescence 
quenching. The data are plotted and fitted to the equation F= {2F0KD- F∞*b+ F∞*(b
2
-4 
[eIF4F][RNA])
1/2 
}/{b+ (b
2
-4 [eIF4F][RNA])
1/2 
}(Thorp, McKenzie et al. 1996) where F0 : 
fluorescence intensity before titration, F∞ : fluorescence intensity when IRE saturated binding 
with eIF4F, b= KD +[eIF4F] + [RNA] (Fig 26) (Table 7). IRP1 binding to capped or non-capped 
the first 73 nt 5’ noncoding region of ferritin mRNA is shown (Fig 27) (Table 7). 
Both IRP 1 and eIF4F have no significant difference in binding between capped and uncapped 
the first 73 nt 5’ noncoding region of ferritin mRNA.  
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Figure 25 The secondary structure of the first 73 nt of ferritin mRNA (Harrell, McKenzie et al. 
1991) 
The first 73nt of ferritin mRNA is predicted to have a large hairpin structure with the IRE inside. 
The IRE region is indicated in the solid line.  
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Figure 26 eIF4F binding with capped or non-capped first 73nt of ferritin mRNA 
The intrinsic fluorescence intensity change of eIF4F protein (50 nM) was monitored with 
increasing RNA concentration. The uncapped first 73 nt of ferritin mRNA (Square ■) binds to 
eIF4F with high binding affinity (KD: around 10 nM
*
). The capped first 73 nt of ferritin mRNA 
(Circle ●) binds to eIF4F with high binding affinity (KD:13.5±2.4 10 nM
*
). 
*
Both the capped and 
uncapped 73nt ferritin mRNA shows high binding affinity to eIF4F. However with 50 nM eIF4F 
protein, KD could not be accurately determined. However with 50 nM IRP protein, KD could not 
be accurately determined below 10 nM. Decreasing protein concentration in the titration could 
not give enough signals to measure binding affinity.  
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Figure 27  IRP1 binding with capped or non-capped first 73nt of ferritin mRNA 
The intrinsic fluorescence intensity change of IRP1 protein (50 nM) was monitored with 
increasing RNA concentration. The uncapped first 73 nt of ferritin mRNA (Square ■) bound to 
IRP with high binding affinity (KD: 11.7±2.7 nM). The capped first 73 nt of ferritin mRNA 
(Circle ●) bound to IRP1 with high binding affinity (KD: around 10 nM).  
*
Both the capped and 
uncapped 73nt ferritin mRNA showed high binding affinity to IRP. However with 50 nM IRP 
protein, KD could not be accurately determined below 10 nM. Decreasing protein concentration 
in the titration could not give enough signals to measure binding affinity.  
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 m7GTP capped the first 73 
nt of ferritin mRNA 
Uncapped the first 73 nt of 
ferritin mRNA 
eIF4F (nM) 13.5±2.4 Around 10 
IRP1 (nM) Around 10 11.7±2.7 
 
Table 7 Disassociation Constants, KD, of eIF4F or IRP1 binding with first 73 nt of ferritin 
mRNA (capped or uncapped ). 
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eIF4G middle domain  binds to ferritin IRE-RNA and mitochondrial aconitase IRE-RNA. 
Among three subunits of eIF4F, the subunit is responsible for IRE-RNA binding is not known.  
With recent evidence of RNA binding motifs in eIF4G (Takagi, Shi et al. 1998), the candidate 
for IRE-RNA binding was eIF4G.  The middle domain of eIF4G has been proven to have RNA 
binding motifs (Epsztejn, Kakhlon et al. 1997). In order to test whether eIF4G has binding 
affinity to IRE-RNA, the eIF4G middle domain (626-1045) and eIF4G C terminal domain (1045-
1560) were expressed and purified from E.coli. The eIF4G middle domain was shown to bind 
with ferritin IRE-RNA (KD =122.1±21.8 nM) (Fig 28) and mitochondrial aconitase IRE (KD 
=81.2±11.4 nM) (Fig30). The eIF4G middle domain also competitively binds to ferritin IRE-
RNA with IRP1 (Fig 29). At the same time, eIF4G C terminal domain was shown no binding 
with ferritin IRE-RNA (Fig 31).    
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Figure 28 eIF4G middle domain (626-1045) binding to ferritin IRE –RNA 
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.) 
labeled ferritin IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, emission- 520 
nm)  in titration buffer. eIF4G middle domain tightly binds to ferritin IRE-RNA  (KD 
=122.1±21.8 nM). 
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Figure 29 Competitive binding of eIF4G middle domain (626-1045) and IRP1 to Ferritin IRE-
RNA 
50 nM ferritin IRE-RNA with various concentration of IRP1 (shows in inset) was added with 
eIF4G middle domain protein. Convergence of lines (1/[eIF4GM] vs 1/∆r ) on the Y axis (circle) 
indicating competitive binding 
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Figure 30 eIF4G middle domain (626-1045) binding to mitochondrial aconitase IRE –RNA 
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.) 
labeled mitochondrial aconitase IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, 
emission- 520 nm)  in titration buffer. eIF4G middle domain tightly binds to mitochondrial 
aconitase IRE-RNA  (KD =81.2±11.4 nM). 
 
 
62 
 
 
 
Figure 31 eIF4G C terminal (1045-1560)  does not bind to ferritin IRE –RNA 
Protein binding to RNA monitored by changes in 5’ fluorescein(Ohgami, Campagna et al.) 
labeled ferritin IRE-RNA (50 nM) fluorescence anisotropy (excitation- 490 nm, emission- 520 
nm)  in titration buffer. eIF4G C terminal does not binds to ferritin IRE-RNA  (Circle ○), 
whereas eIF4G middle domain binds to ferritin IRE-RNA (KD =122.1±21.8 nM) (Diamond ◊). 
 
 
 
○ eIF4G C terminal  
◊ eIF4G Middle domain 
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Summary of protein/IRE-RNA complexes binding affinity 
 
 
Table 8 Protein/IRE-RNA complexes binding affinity 
eIF4G M: eIF4G middle domain (626-1045) expressed in E.coli 
eIF4G C: eIF4G c terminal (1045-1560) expressed in E.coli 
Ft IRE: ferritin IRE-RNA 
Mt IRE: mitochondrial aconitase IRE-RNA 
Capped 73 nt: The first 73 nt of ferritin mRNA capped with m7GTP  
Uncapped 73 nt: The first 73 nt of ferritin mRNA 
*Data from the reference (Khan, Walden et al. 2009)  
 
 
 
 Ft IRE Mt IRE Capped 73 nt  Uncapped 73 nt 
eIF4F  (nM) 39.8±5.6 32.9±5.4 13.5±2.4 Less than 10 
IRP 1 (nM) *14.2±0.3 *41.3±0.7 Less than 10  11.7±2.7 
eIF4G M (nM) 122.1±21.8 81.2±11.4 Not Available Not Available 
eIF4G C (nM) No binding Not Available Not Available Not Available 
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Discussion 
The small RNA structure in the 5’ noncoding region of mRNA affecting eukaryotic protein 
synthesis is illustrated by the ability of IRE-RNA to bind, competitively, to two regulatory 
proteins. Besides binding to IRP, a protein synthesis inhibitor, IRE-RNA also binds eIF4F which 
is the protein synthesis enhancer and known as a rate-limiting step in protein synthesis.  As a 
well-known mRNA translation control mechanism, phosphorylation of eIF proteins themselves 
or eIF binding proteins, alters binding affinity of the proteins with mRNA under a variety of 
cellular conditions (Jackson, Hellen et al. 2010). A novel mechanism of translation initiation 
mechanism regulated by iron is shown in this research. Iron interacting with the small RNA 
structure located in the noncoding region of mRNA such as IRE-RNA stabilizes eIF/RNA 
binding.  Increases in eIF4F/ ferritin IRE-mRNA binding facilitated by Fe
2+
 occur at 
concentrations 100 times lower than with Mg
2+
 and with stabilities  20-1000  times higher than 
for eIF4F binding to - globin mRNA or the m7G cap structure (Lomakin, Hellen et al. 2000) 
(Marintchev, Edmonds et al. 2009).   
Small, shapely molecules such as Cu
1+
- phenathroline or Ru
2+
-tris(bipyridyl) binding to   
selective sites on IRE-RNA (Wang, Sczekan et al. 1990; Thorp, McKenzie et al. 1996) has been 
known for some time. The possibility of Fe
2+ 
binding to IRE-RNA in ferritin mRNA was 
suggested by the results of IRE-RNA cleavage with Fe
2+
 and hydrogen peroxide (Lv, Yan et al. 
2012). The unusual pattern of hypersensitive cleavage sites was initially explained as solvent 
access prevented by RNA folding, a supposition that was not supported by NMR structures 
obtained later (Gdaniec, Sierzputowska-Gracz et al. 1998; Zhao, Jian et al. 2012). Alternatively, 
the hypersensitive sites could indicate Fe
2+
/RNA binding sites. Experiments with 2AP 
substituted IRE-RNA showed that Fe
2+
 altered the conformation of both the terminal IRE loop 
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and the C8 bulge. A15 and C8 are part of the two IRE-RNA/IRP1 contact sites and have multiple 
contacts (Ke, Wu et al. 1998; Hall, Williams et al. 2004; Walden, Selezneva et al. 2006). There 
are some shortcomings of 2AP experiments. 2AP experiments cannot give detailed information 
of conformational changes in all nucleotides,   and it cannot identify the Fe
2+
 binding sites on 
IRE-RNA. Other experimental methods need to be employed in Fe
2+ 
/IRE-RNA interaction 
research.  In this research, all experiments were conducted in vitro, in the solution.  How do 
IRP/IRE and eIF4F/IRE complexes respond to physiological iron concentration changes? By 
fluorescence quenching analysis and potentiometric methods (Epsztejn, Kakhlon et al. 1997; 
Hider and Kong 2011), physiologically free [Fe
2+
] was measured at ~0.5-1.0 µM in normal 
mammalian cells. At intracellular [Fe
2+
] ~5-10 µM, detectable ferritin protein accumulations can 
be immunologically measured. These data show, at  5-10 µM  [Fe
2+
] in solution,  a 6:1 decrease 
in IRP binding and a 1.5:1 increase in eIF4F binding (Figure 14).  Because eIF4F and IRP bind 
competitively (Figure 13), the IRE/eIF4F complex can increase 8:1, for similar IRP:eIF4F 
concentrations at 5 µM [Fe
2+
]. The effect could be 80:1, at 50 µM Fe
2+
. 
A model of ferritin IRE-mRNA riboregulator function (Figure 32) was proposed, which 
combines Fe
2+ 
regulating IRE-mRNA-IRP inhibition of protein synthesis with Fe
2+
 regulating 
IRE-mRNA-eIF4F enhancement of protein synthesis (Zahringer, Baliga et al. 1976; Theil and 
Eisenstein 2000; Wallander, Leibold et al. 2006). The model also includes the inactivation of 
IRP for IRE-RNA binding from previous models (Johnson, Dean et al. 2005; Rouault 2006; 
Leipuviene and Theil 2007; Salahudeen, Thompson et al. 2009; Vashisht, Zumbrennen et al. 
2009). Increasing cellular concentrations of Fe
2+
 will induce IRE-RNA conformation change, 
lower RNA/IRP affinity, and increase eIF4F binding affinity, which leads to ribosome assembly 
and mRNA translation.  
66 
 
 
 
 
Figure 32 Model for IRE-RNA riboregulator action 
1) At low iron concentration, ribosome assembly is inhibited by IRP binding to IRE-mRNA.    
2) When iron concentration increases, Fe2+ causes an IRE-RNA conformational change 
which favors eIF4F/IRE-RNA binding and decreases IRP/IRE-RNA binding.  
3) After eIF4F binding to the IRE-mRNA, eIF4F recruits the ribosome and ferritin protein 
synthesis (translation and expression) begins.  
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The m
7
GTP cap structure is a strong positive control element in eukaryotic protein synthesis. 
The IRE structure is located within 40 nt of  m
7
GTP cap in the 5’ noncoding region (Gebauer 
and Hentze 2004). Binding affinity showed the m
7
GTP cap had no effect on IRP or eIF4F 
binding to mRNA. Previous studies showed that IRE structure has a greater effect on ferritin 
mRNA translation in the depleting IRP protein translation system than 5’ m7GTP cap. Ferritin 
mRNA also translates without 5’end cap but not IRE structure (Dix, Lin et al. 1992). eIF4F 
binding with IRE-RNA indicates that IRE can be a positive control element for mRNA 
translation. Studies show that IRE is still a positive control element for mRNA translation 
without m
7
GTP cap. At the same time, there is no difference between eIF4F binding to ferritin 
IRE-RNA and mitochondrial aconitase IRE-RNA but a significant difference between IRP1 
binding to ferritin IRE-RNA and mitochondrial aconitase IRE-RNA (Table 22). All these 
evidence implies eIF4F/IRE complex may have other roles in translation initiation besides 
interacting IRP/IRE system. Without m
7
GTP cap, IRE binds to eIF4F and then helps ribosome 
access mRNA.  In the eukaryotic cell, internal ribosome entry site (IRES) can recruit the 
ribosome to mRNA independent of the m
7
GTP Cap (Gebauer and Hentze 2004; Komar and 
Hatzoglou 2011). Besides similar name, IRE may functions as IRES in the IRE mRNA to initiate 
translation.  
In order to further understand IRE-RNA regulating mRNA translation, the kinetic of eIF4F/IRE 
RNA and IRP/IRE-RNA was studied. These data show that IRP/IRE-RNA complex has a much 
shorter lifetime than eIF4F/IRE-RNA complex, but IRP1 binds to and dissociates from IRE-
RNA much faster than eIF4F. As a negative control factor in IRE-RNA translation, the IRP1 
needs to bind to IRE-RNA more flexibly than eIF4F in order to respond to cellular iron 
concentration changes promptly. On the other hand, eIF4F binding to mRNA is the rate 
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determined step in protein translation initiation (Schutz, Bumann et al. 2008). Therefor a longer 
life time of eIF4F/IRE-RNA complex is required to stabilize the ribosome on mRNA.  
As a three subunits complex, which subunit is responsible for IRE-RNA binding in eIF4F is 
answered. The middle domain of eIF4G has been shown to have RNA binding motifs 
independent of other two subunits (Sonenberg and Hinnebusch 2009). The IRE/eIF4G binding 
results showed that the middle domain of eIF4G binds to IRE-RNA (Table 22). Besides high 
affinity between eIF4G middle domain and IRE-RNA, eIF4G middle domain also competitively 
binds to IRE with IRP1. The eIF4G C terminal domain was also tested to see whether it binds to 
ferritin IRE-RNA. The results showed that eIF4G C terminal domain has no binding affinity to 
the ferritin IRE (Figure 31), which verified the eIF4G middle domain binds to ferritin IRE-RNA. 
The IRE has been identified as a control element in iron metabolic proteins synthesis since late 
last century (Zahringer, Baliga et al. 1976; Wang, Sczekan et al. 1990; Lv, Yan et al. 2012).  
Now IRE is also found in mRNAs encoding a cell cycle protein (Sanchez, Galy et al. 2007), α–
hemoglobin chaperone (dos Santos, Dore et al. 2008) and amyloid precursor protein (Beard, 
Burton et al. 1996; Proudhon, Wei et al. 1996; Cho, Cahill et al. 2010). Recent extensions of the 
IRE-RNA family indicate that IRE-mRNA control of protein synthesis affects a number of 
metabolic processes in animal cells and may be more general than previously thought.  
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